Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 9
Submit an article Journal homepage
928
Views
13
CrossRef citations to date
0
Altmetric
Respiratory

Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis

Ellison D. SuthoffVertex Pharmaceuticals Incorporated, Boston, MA, USA;
,
Mac BonafedeTruven Health Analytics, Cambridge, MA, USA;
,
Brendan LimoneTruven Health Analytics, Cambridge, MA, USA;
,
Lasair O’CallaghanVertex Pharmaceuticals Incorporated, Boston, MA, USA;
,
Gregory S. SawickiDivision of Respiratory Diseases, Boston Children’s Hospital, Boston, MA, USA;
&
Jeffrey S. WagenerDepartment of Pediatrics, University of Colorado Medical School, Aurora, CO, USACorrespondence[email protected]
Pages 845-851 | Received 08 Feb 2016, Accepted 06 Apr 2016, Published online: 27 Apr 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zumi Mehta, Khalid M. Kamal, Richard Miller, Jordan R. Covvey & Vincent Giannetti. (2021) Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database. Journal of Drug Assessment 10:1, pages 62-67.
Read now
Zhe Hui Hoo, Martin J Wildman, Michael J Campbell, Stephen J Walters & Benjamin Gardner. (2019) A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis. Patient Preference and Adherence 13, pages 283-294.
Read now
Siva Narayanan, Jochen G. Mainz, Smeet Gala, Harold Tabori & Daniel Grossoehme. (2017) Adherence to therapies in cystic fibrosis: a targeted literature review. Expert Review of Respiratory Medicine 11:2, pages 129-145.
Read now

Articles from other publishers (10)

Gregory S. Sawicki, Andrea Goodman, Callie Bacon, Lauren Collins, Jonathan Greenberg, Christina Duncan, Carla Frederick, Shelby Luebbert, Sylvia Mazuera, Deepika Polineni, Lori L. Stark, Cynthia George & Kristin A. Riekert. (2023) Partners in research: The success with therapies research consortium and the CF community unite to improve self-management. Journal of Cystic Fibrosis 22:5, pages 830-835.
Crossref
Yasmin Al‐Din, Carol Dryden, Gordon MacGregor, David Young & Cristina Coelho. (2023) Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population. The Clinical Respiratory Journal.
Crossref
Nicholas J. Simmonds, C. Kors van der Ent, Carla Colombo, Nils Kinnman, Cynthia DeSouza, Teja Thorat, Marci L. Chew, Keval Chandarana & Carlo Castellani. (2023) VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non–G551D-CFTR gating mutations. Journal of Cystic Fibrosis 22:1, pages 124-131.
Crossref
Ryan C. Perkins, Mahek Shah & Gregory S. Sawicki. (2021) An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis. Pediatric Pulmonology 56:5, pages 928-938.
Crossref
Jamie Duckers, Beth Lesher, Teja Thorat, Eleanor Lucas, Lisa J. McGarry, Keval Chandarana & Fosca De Iorio. (2021) Real-World Outcomes of Ivacaftor Treatment in People with Cystic Fibrosis: A Systematic Review. Journal of Clinical Medicine 10:7, pages 1527.
Crossref
Lucie Olivereau, Viviane Nave, Stephan Garcia, Marie Perceval, Muriel Rabilloud, Isabelle Durieu & Quitterie Reynaud. (2020) Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France. Journal of Cystic Fibrosis 19:3, pages 402-406.
Crossref
Miquéias Lopes-Pacheco. (2020) CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Frontiers in Pharmacology 10.
Crossref
Scott D. Grosse, Thuy Quynh N. Do, Michelle Vu, Lisa B. Feng, Jay G. Berry & Gregory S. Sawicki. (2018) Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016. Pediatric Pulmonology 53:12, pages 1611-1618.
Crossref
David M. Orenstein & Robert N. Abood. (2018) Cost(s) of caring for patients with cystic fibrosis. Current Opinion in Pediatrics 30:3, pages 393-398.
Crossref
Lisa B. FengScott D. GrosseRidgely Fisk GreenAliza K. FinkGregory S. Sawicki. (2018) Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis–Related Hospitalizations. Health Affairs 37:5, pages 773-779.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.